Abiopharma

Shangri-La Asia Limited was incorporated in Bermuda on 14 August 1992. It has
a primary listing on the Hong Kong Stock Exchange and a secondary listing on
the SGX-ST. The Company is the listed vehicle of the Shangri-La Group. Its
Singapore subsidiary, Shangri-La Hotel Limited, was delisted from the SGX-ST on
23 February 2001.
The principal activity of the Company is investment holding. The principal
activities of the Companys subsidiaries are the ownership and operation of
hotels and associated properties and the provision of hotel management and
related services. The Companys subsidiaries are also the registered
proprietors of various trademarks and service marks in various countries,
including the brand names "Shangri-La", "Traders", "Rasa","Summer Palace" and
"Shang Palace".
The principal activities of the Companys associated companies are the leasing
of office, commercial, residential and exhibition hall space and serviced
apartments as well as the ownership and operation of hotels.

Additional info from SGX:

Shangri-La Asia Limited was incorporated in Bermuda on 14 August 1992. It has
a primary listing on the Hong Kong Stock Exchange and a secondary listing on
the SGX-ST. The Company is the listed vehicle of the Shangri-La Group. Its
Singapore subsidiary, Shangri-La Hotel Limited, was delisted from the SGX-ST on
23 February 2001.
The principal activity of the Company is investment holding. The principal
activities of the Companys subsidiaries are the ownership and operation of
hotels and associated properties and the provision of hotel management and
related services. The Companys subsidiaries are also the registered
proprietors of various trademarks and service marks in various countries,
including the brand names "Shangri-La", "Traders", "Rasa","Summer Palace" and
"Shang Palace".
The principal activities of the Companys associated companies are the leasing
of office, commercial, residential and exhibition hall space and serviced
apartments as well as the ownership and operation of hotels.